Terminal room disinfection: how much BETR can it get?

Lancet

Department of Infection Prevention and Control, Methodist Dallas Medical Center, Dallas, TX 75203, USA.

Published: February 2017

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(16)32412-6DOI Listing

Publication Analysis

Top Keywords

terminal room
4
room disinfection
4
disinfection betr
4
betr get?
4
terminal
1
disinfection
1
betr
1
get?
1

Similar Publications

Background: Acute heart failure (AHF) poses significant diagnostic challenges in the emergency room (ER) because of its varied clinical presentation and limitations of traditional diagnostic methods. This study aimed to develop and evaluate a deep-learning model using electrocardiogram (ECG) data to enhance AHF identification in the ER.

Methods: In this retrospective cohort study, we analyzed the ECG data of 19,285 patients who visited ERs of three hospitals between 2016 and 2020; 9,119 with available left ventricular ejection fraction and N-terminal prohormone of brain natriuretic peptide level data and who were diagnosed with AHF were included in the study.

View Article and Find Full Text PDF

Background: Clinical trials for assessing the effects of infection prevention and control (IPC) interventions are expensive and have shown mixed results. Mathematical models can be relatively inexpensive tools for evaluating the potential of interventions. However, capturing nuances between institutions and in patient populations have adversely affected the power of computational models of nosocomial transmission.

View Article and Find Full Text PDF

Antimicrobial Silicon Rubber Crosslinked with Bornyl-Siloxane.

Macromol Rapid Commun

January 2025

State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, 100029, P. R. China.

Silicone rubber (SiR) has a wide range of medical applications, but it lacks antimicrobial properties, leading to potential infection issues with related implants or medical devices. Most studies focus on adding anti-bacterial agents or surface modification, which usually result in composites with anti-bacterial properties, rather than synthesizing SiR with intrinsically antimicrobial performances. To tackle this issue, a double substituted bornyl-siloxane crosslinker (BC) is designed.

View Article and Find Full Text PDF

Method Evaluation of the QuidelOrtho Diagnostics Vitros NT-proBNP II Assay.

J Clin Med

December 2024

Department of Pathology and Laboratory Medicine, Children's Hospital Los Angeles, 4650 Sunset Blvd, M/S #32, Los Angeles, CA 90027, USA.

N-terminal-proBNP (NT-proBNP) is a biomarker released into the blood in response to heart failure, reflecting the extent of cardiac stress and damage. QuidelOrtho Diagnostics released its latest reformulation of its NT-proBNP assay, the Vitros NT-proBNP II assay. This study aims to evaluate the analytical performance of the Vitros NT-proBNP II assay.

View Article and Find Full Text PDF
Article Synopsis
  • Medical simulation education has expanded to remote learning, enabling engagement for pediatric clinicians to treat adult patients using advanced techniques like ACLS.
  • The curriculum included online training sessions focusing on critical cases such as narcotic overdose and pulmonary embolism, and utilized assessments to measure knowledge retention and comfort levels over time.
  • Results showed high participant satisfaction and significant improvements in clinical knowledge related to ACLS and PALS, highlighting the effectiveness of tele-simulation for enhancing medical education.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!